Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026 and Aug 2026.
- Largest single sale: $2.4M (20,000 shares) of Merck & Co. on Feb 5, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Merck & Co. (MRK) | EVP, Access, Policy & Comms | Jul 8, 2022 | Aug 13, 2026 |
| Biogen (BIIB) | Former Head of Glob Prod Strat & Com | Nov 16, 2017 | Feb 23, 2022 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 13, 2026, Merck & Co.: sold 10,000 shares for $1.4M, no plan disclosed. 1 filing: 1
- Aug 6, 2026, Merck & Co.: sold 15,000 shares for $2.0M, no plan disclosed. 1 filing: 1
- Apr 29, 2026, Merck & Co.: 1,967 shares vested; 969 shares withheld by the company for taxes. 1 filing: 1
- Feb 12, 2026, Merck & Co.: sold 10,000 shares for $1.2M, no plan disclosed. 1 filing: 1
- Feb 9, 2026, Merck & Co.: sold 10,000 shares for $1.2M, no plan disclosed. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.